Elanco Animal Health Incorporated Common Stock (ELAN) — Analysis Summary
Elanco Animal Health Incorporated Common Stock (ELAN) has a market cap of $12.13B with year-over-year revenue growth of +6.2%. Net margin stands at -4.9%. The stock trades at a P/E ratio of -50.1.
Key Takeaways
- Revenue changed +6.2% year-over-year
- Net margin of -4.9%
- P/E ratio of -50.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ELAN posted revenue growth of +6.2% and trades at a P/E of -50.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.